随着基金二季报持续披露,更多知名基金经理的最新持仓动向曝光。《每日经济新闻》记者注意到,中欧基金葛兰管理的中欧医疗健康,二季度加码创新药,多只创新药个股新进前十大重仓股,而多只中药股退出前十大。另外,兴证全球基金谢治宇管理的兴全合润,二季度减持了比亚迪、海尔智家,转而重仓分众传媒、蓝思科技。值得一提的是,其管理的兴全合宜,二季度偏爱创新药,多只个股进入前十大。葛兰二季度加码创新药先从中欧医疗健康...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.